Soleno Therapeutics, Inc. (SLNO)
53.01
+0.02
(+0.04%)
USD |
NASDAQ |
May 15, 16:00
53.02
+0.01
(+0.02%)
After-Hours: 20:00
Soleno Therapeutics EPS Diluted (Quarterly) : 0.5913 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 1.914 |
| Nektar Therapeutics | -1.815 |
| XOMA Royalty Corp. | 0.173 |
| Apellis Pharmaceuticals, Inc. | 0.142 |
| Forian, Inc. | -0.1079 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 31.38M |
| Revenue (Quarterly) | 94.60M |
| Total Expenses (Quarterly) | 63.23M |
| Enterprise Value | 2.562B |
| Gross Profit Margin (Quarterly) | 98.73% |
| Profit Margin (Quarterly) | 33.17% |
| Earnings Yield | 3.32% |
| Operating Earnings Yield | 3.17% |
| Normalized Earnings Yield | 3.400 |